Reporting Manager
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Symbol
FBRX
Shares outstanding
6,414,114 shares
Disclosed Ownership
640,770 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:33:55 UTC
Date of event
31 Dec 2024
Next filing
04 Aug 2025

Sponsored

Quoteable Key Fact

"TYBOURNE CAPITAL MANAGEMENT (HK) LTD disclosed 10% ownership in Forte Biosciences, Inc. Common Stock (FBRX) on 31 Dec 2024."

Quick Takeaways

  • TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock (FBRX).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 10% 640,770 0 640,770 /s/ Catherine Cheung Catherine Cheung, Chief Operating Officer
TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED 10% 640,770 0 640,770 /s/ Viswanathan Krishnan Viswanathan Krishnan, Director
Tybourne Capital Management Ltd 10% 640,770 0 640,770 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Tybourne Kesari Ltd 10% 640,770 0 640,770 /s/ Viswanathan Krishnan Viswanathan Krishnan, Principal
Krishnan Viswanathan 10% 640,770 0 640,770 /s/ Viswanathan Krishnan Viswanathan Krishnan, Individually